Ancora Advisors, LLC Mei Pharma, Inc. Transaction History

Ancora Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.52 - $3.24 $321,678 - $413,586	-127,650 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.92 - $4.1 $53,088 - $113,364	27,650 Added 27.65%	127,650 $337,000
Q2 2018 Aug 10, 2018	SELL	$1.89 - $4.95 $127,503 - $333,936	-67,462 Reduced 40.28%	100,000 $394,000
Q4 2017 Feb 14, 2018	BUY	$1.91 - $2.83 $15,853 - $23,489	8,300 Added 5.21%	167,462 $352,000
Q3 2017 Nov 14, 2017	BUY	$2.44 - $2.91 $388,355 - $463,161	159,162	159,162 $427,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $389M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.